FDA issued a Warning Letter to Tubilux Pharma Spa on 7/6/2017 as a result of this inspection.
483 Tubilux Pharma Spa Dec 2016

483 Tubilux Pharma Spa Dec 2016

Milva Melendez FDA$119.00 - Available Now

FDA investigators audited the Tubilux Pharma Spa - Pomezia, Italy facility and issued inspectional observations (via FDA 483) on 09 Dec 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 09 Dec 2016
  • Location: Pomezia, Italy
  • FEI: 3003854110
Add To Cart